Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin
<p><span>Naturally occurring point mutations in the <i>HBG</i> promoter switch hemoglobin synthesis from defective adult beta-globin to fetal gamma-globin in sickle cell patients with hereditary persistence of fetal hemoglobin (HPFH) and ameliorate the clinical severity. Inspired by this natural phenomenon, we tiled the highly homologous<i> HBG1</i> and <i>HBG2 </i>proximal promoters using adenine and cytosine base editors that avoid the generation of large deletions. Among the novel regulatory region identified, base editing at -123 region induced HbF to a higher level than disruption of a well-known BCL11A binding site in erythroblasts derived from healthy donor CD34+ HSPC. We further demonstrated <i>in vitro</i> that the introduction of -123T>C and -124T>C HPFH-like mutations drives gamma-globin expression by creating a <i>de novo</i> binding site for the master erythroid regulator KLF1. Overall, our findings shed light on so far unknown regulatory elements within the <i>HBG</i> promoter and identified additional targets for therapeutic upregulation of fetal hemoglobin. </span></p>
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 0
- Harmonization
- 12
- Access
- 12
- Reuse readiness
- 0
- Engagement
- 4
Dataset details
- Repository
- dryad
- Published
- December 11, 2022
- License
- cc-zero
- DOI
- 10.5061/dryad.bzkh1897h
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.